Zobrazeno 1 - 10
of 336
pro vyhledávání: '"K, Loeschke"'
Autor:
S. Kolb, D. Sailer, J. Barnert, H. J. Gramm, J. Goecke, P. Schauder, V. Hammann, U. Brenner, L. Frick, H. J. Steinhardt, W. Brandmair, L. Lehr, K. Loeschke, H. Towliati
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 112:1450-1453
Parenteral nutrition via an indwelling central venous catheter was undertaken at home over a total period of 24,747 days in 34 patients with the short-bowel syndrome (of various causes). In some of the patients there developed complete adaptation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fee298a8796f508dfe2f1ad777c1639f
https://doi.org/10.1055/s-2008-1068268
https://doi.org/10.1055/s-2008-1068268
Autor:
W. Bommer, Wolfgang F. Caspary, M. Classen, R. Dölp, R. Ecknauer, J. Erckenbrecht, G. E. Feurle, D. Filler, A. Gangl, K. E. Grund, K. Gyr, F. Hagenmüller, V. Helmstädter, H. W. von Heyden, K. Hübner, B. Husemann, F. Kümmerle, V. Lenner, K. Loeschke, H. Lorenz-Meyer, H. Malchow, E. M. H. Mathus-Vliegen, H. Menge, H. Mergerian, B. Miller, U. Rasenack, B. Reichlin, E. O. Riecken, W. Rösch, H. Ruppin, A. Schaudig, H. W. Schreiber, K. H. Soergel, G. N. J. Tytgat, M. Wienbeck, K. Winckler, R. Winkler
Autor:
R. M. Huber, K. Loeschke, H. Hallfeldt, H. E. Feucht, W. Heldwein, Chr. Zietz, W. A. Voderholzer
Publikováno v:
Zeitschrift für Gastroenterologie. 38:637-642
We present a 28-year-old women with a 3 yr history of duodenal ulcers. Following four treatment attempts to eradicate helicobacter pylori she was admitted because of gastric outlet obstruction and a weight loss of 20 kg within the last two years. End
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d2bb42d34a49a2ca155df17dcf80d51
https://doi.org/10.1055/s-2000-7505
https://doi.org/10.1055/s-2000-7505
Autor:
V Gross, T Andus, K W Ecker, A Raedler, K Loeschke, M Plauth, J Rasenack, A Weber, M Gierend, K Ewe, J Scholmerich, null Budesonide Study Group
Publikováno v:
Gut. 42:493-496
Background—The relapse rate after steroid induced remission in Crohn’s disease is high. Aims—To test whether oral pH modified release budesonide (3 × 1 mg/day) reduces the relapse rate and to identify patient subgroups with an increased risk o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91b116d5b2081f7be60e546617c105dd
https://doi.org/10.1136/gut.42.4.493
https://doi.org/10.1136/gut.42.4.493
Publikováno v:
Klinische Wochenschrift. 68:709-717
Thirty-seven patients with volume-retaining disorders (liver cirrhosis with ascites, n = 8; heart failure NYHA III-IV, n = 12; endstage renal failure, n = 17) and twelve healthy age-matched controls were given a small dose (33 micrograms) of hANF (hu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b2bf5c14bb0c9bcab420da47b8f6752
https://doi.org/10.1007/bf01647578
https://doi.org/10.1007/bf01647578
Publikováno v:
Zeitschrift fur Gastroenterologie. 40(10)
A 26-year-old woman presented with elevated liver enzymes, which were diagnosed two months ago. Examination revealed mild proximal muscle weakness, though the patient herself did not realise any impairment. The abdominal ultrasound and the histology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4c1d63ccc68e24115100c905f7f2b714
https://pubmed.ncbi.nlm.nih.gov/12436356
https://pubmed.ncbi.nlm.nih.gov/12436356
Publikováno v:
Der Nervenarzt. 72(11)
Little is known about possibilities of chronic hepatitis C treatment with interferon-alpha (IFN-alpha) in psychiatric patients continuously taking antipsychotics. We report on a 28-year-old hepatitis C-positive man with paranoid psychosis. He was suc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f32a139e72193121f07b38e33278270b
https://pubmed.ncbi.nlm.nih.gov/11758095
https://pubmed.ncbi.nlm.nih.gov/11758095
Autor:
B, Siegmund, C, Folwaczny, L, Bader, B, Otto, M, Hoelscher, G, Leinsinger, P, Herzer, K, Loeschke
Publikováno v:
Der Internist. 41(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c7f387563aebb1b75b9b6e10186fc5f0
https://pubmed.ncbi.nlm.nih.gov/11006877
https://pubmed.ncbi.nlm.nih.gov/11006877
Autor:
K, Fellermann, M, Steffen, J, Stein, A, Raedler, J, Hämling, D, Ludwig, K, Loeschke, E F, Stange
Publikováno v:
Alimentary pharmacologytherapeutics. 14(2)
Mycophenolate mofetil (MMF) is a new immunosuppressant with pharmacodynamic properties comparable to azathioprine. Recent reports found MMF to be effective in inflammatory bowel disease (IBD).An open-label prospective and uncontrolled multicentre 6 m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::37f8b31f9a9792a34470d5248ec742f7
https://pubmed.ncbi.nlm.nih.gov/10651657
https://pubmed.ncbi.nlm.nih.gov/10651657